$11.19
-0.13-1.15%
Last update: 11:59 AM
15 minutes delayed
Comments
Loading...
Sector
Healthcare
Region
US
AUM
83.48M
Fund Score
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Quotes, Forecast and News Summary
Global X Genomics & Biotechnology ETF (NASDAQ: GNOM) stock price, news, charts, stock research, profile.
| Open | $11.33 |
| High | $11.33 |
| 52 Wk High | $12.53 |
| AUM | 83.48M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | 13.74K |
| Market Cap | $14.08B |
| Mgmt Fee | 0.5% |
| P/E Ratio | 38.23 |
| Prev. Close | $11.32 |
| Low | $11.15 |
| 52 Wk Low | $8.63 |
| Shares Out | 9.12M |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | 59.68K |
| Beta | 1.11 |
| Avg. Expense Ratio | 0.5% |
| P/B Ratio | 3.38 |
Recent News
FAQ
How do I buy Global X Genomics & Biotechnology ETF (GNOM) stock?
You can purchase shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) through any online brokerage.
Who are Global X Genomics & Biotechnology ETF (GNOM) competitors?
There are no as such competitors for Global X Genomics & Biotechnology ETF.
What is the forecast, or price target, for Global X Genomics & Biotechnology ETF (GNOM) stock?
There is no analysis for Global X Genomics & Biotechnology ETF to provide a consensus price target.
What is the current price for Global X Genomics & Biotechnology ETF (GNOM)?
The stock price for Global X Genomics & Biotechnology ETF (NASDAQ: GNOM) is $11.19 last updated September 23, 2024 at 11:59 AM EDT.
Does Global X Genomics & Biotechnology ETF (GNOM) pay a dividend?
There are no upcoming dividends for Global X Genomics & Biotechnology ETF.
When is Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) reporting earnings?
Global X Genomics & Biotechnology ETF does not have any upcoming earnings scheduled.
Is Global X Genomics & Biotechnology ETF (GNOM) going to split?
There is no upcoming split for Global X Genomics & Biotechnology ETF.
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | Apr 5, 2019 |
| Managers | Vanessa Yang Sandy Lu Wayne Xie Nam To |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
The Fund invests at least 80 percent of its total assets in the securities of the Solactive Genomics Index (Underlying Index). The Fund's 80 percent investment policy is non-fundamental and requires 60 days prior written notice to shareholders before it can be changed. The Fund may lend securities representing up to one-third of the value of the Funds total assets (including the value of the collateral received).
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| ALNY | Alnylam Pharmaceutical... | 5.66% |
| RNA | Avidity Biosciences In... | 5.52% |
| TECH | Bio-Techne Corp | 4.41% |
| LEGN | Legend Biotech Corp | 4.29% |
| ARWR | Arrowhead Pharmaceutic... | 4.22% |
| NTLA | Intellia Therapeutics ... | 4.19% |
| MYGN | Myriad Genetics Inc | 4.08% |
| SRPT | Sarepta Therapeutics I... | 3.94% |
| NTRA | Natera Inc | 3.84% |
| MRNA | Moderna Inc | 3.76% |